Dow Jones

51 915,21

0,48%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

Accueil
Investir
Actions
Etats-Unis
USOTC
Cantabio Pharmaceuticals Inc (EM) (CTBO)
Cantabio Pharmaceuticals Inc (EM) (CTBO) Actualités

Cantabio Pharmaceuticals Inc (EM) (CTBO)

1,01

0,00

( 0,00% )

Mis à jour : 02:00:00

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Amended Statement of Ownership: Private Transaction (sc 13e3/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Quarterly Report (10-q)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...

Amended Statement of Ownership: Private Transaction (sc 13e3/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...

Information Statement - All Other (definitive) (def 14c)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Amended Statement of Ownership: Private Transaction (sc 13e3/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...

Information Statements (revised) (prer14c)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Information Statements (revised) (prer14c)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Amended Statement of Ownership: Private Transaction (sc 13e3/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...

Statement of Ownership: Private Transaction (sc 13e3)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...

Proxy Statement - Other Information (preliminary) (pre 14c)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRE...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRE...

Quarterly Report (10-q)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X]...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

USOTC

CTBO

Cantabio Pharmaceuticals (EM)

BOV

FMSC34

Fresenius Medical Care

Pizza Pizza Royalty (PK)

DOWI

DJSOEP

DJ US Select Oil Explora...

DB Agriculture Double Lo... (PK)

USOTC

PSGTF

Pt Semen Gresik Idr (PK)

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cantabio Pharmaceuticals Inc (EM) (CTBO)

Outils de qualité professionnelle, pour des investisseurs individuels.